Tag: Tenofovir
Study explores hypertension risk in adults on TAF vs. TDF
In a recent study published in JAMA Network Open, a group of researchers assessed the risk of hypertension and statin initiation in adults starting Human Immunodeficiency Virus (HIV) Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir alafenamide fumarate (TAF) compared to those taking emtricitabine/tenofovir disoproxil fumarate (TDF), using data from Kaiser Permanente Southern California (KPSC). Study: Use of Tenofovir […]
